The effect of SGLT-2i administration on red blood cell distribution width in patients with heart failure and type 2 diabetes mellitus: A randomized study

BACKGROUND: Recent studies suggest that the pivotal mechanism of sodium glucose co-transporter-2 inhibitors (SGLT-2i) favorable action in patients with heart failure (HF) and type 2 diabetes mellitus (DM) is the stimulation of erythropoiesis via an early increase in erythropoietin (EPO) production w...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsiadas, Nikolaos, Xanthopoulos, Andrew, Giamouzis, Grigorios, Skoularigkis, Spyridon, Skopeliti, Niki, Moustaferi, Evgenia, Ioannidis, Ioannis, Patsilinakos, Sotirios, Triposkiadis, Filippos, Skoularigis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557218/
https://www.ncbi.nlm.nih.gov/pubmed/36247420
http://dx.doi.org/10.3389/fcvm.2022.984092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557218/
https://www.ncbi.nlm.nih.gov/pubmed/36247420
http://dx.doi.org/10.3389/fcvm.2022.984092

Ejemplares similares